期刊名称:Discussion Papers / Norwegian School of Economics and Business Administration
印刷版ISSN:0804-6824
出版年度:2007
卷号:2007
出版社:Bergen
摘要:We study the impact of regulatory regimes on generic competition and pharmaceutical
pricing using a unique policy experiment in Norway, where reference pricing
(RP) replaced price cap regulation in 2003 for a sub-sample of off-patent products.
We exploit a detailed panel dataset at product level covering a wide set of off-patent
drugs before and after the policy reform. Off-patent drugs not subject to reference
pricing serve as our control group. We find that RP leads to lower relative prices, with
the effect being driven by strong brand-name price reductions, and not increases in
generic prices. We also find that RP increases generic competition, resulting in lower
brand-name market shares. Finally, we show that RP has a strong negative effect on
average prices at molecule level, suggesting significant cost-savings.